HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clomipramine for obsessive-compulsive disorder.

Abstract
Obsessive-compulsive disorder affects about 2 percent of the U.S. population and can be quite disabling. Clomipramine is the only drug approved for the treatment of obsessive-compulsive disorder. Its efficacy is unique among tricyclic antidepressants and may be related to its relatively high potency in affecting serotonergic neurotransmission. The drug has many anticholinergic effects, but it is relatively well tolerated by the patients for whom it is effective. A 0.4 percent incidence of seizures, a potentially serious side effect, has been observed. Other antidepressants that are relatively selective for serotonergic (as opposed to noradrenergic) transmission may be as effective as clomipramine in the treatment of this disorder; controlled studies are under way. Clomipramine at low doses is also effective in the treatment of panic disorder and has been used successfully in the treatment of premature ejaculation.
AuthorsM Feinberg
JournalAmerican family physician (Am Fam Physician) Vol. 43 Issue 5 Pg. 1735-8 (May 1991) ISSN: 0002-838X [Print] United States
PMID2021107 (Publication Type: Journal Article, Review)
Chemical References
  • Clomipramine
Topics
  • Clinical Trials as Topic
  • Clomipramine (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Incidence
  • Obsessive-Compulsive Disorder (drug therapy)
  • Seizures (chemically induced, epidemiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: